Independence over endorsement
Editorial ratings are independent of commission rate. We will publish a critical review of a partner that pays us if the facts warrant it.
Affiliate-supportedIndependent editorialWe never sell medicationSee how
About GLP1Zoom
In 2026, choosing a GLP-1 telehealth provider means navigating a dozen-plus provider offers across 50 state regulatory frameworks, with monthly prices that swing $200–800. Most comparisons online are commission tables in disguise. GLP1Zoom is built differently — a published scoring methodology, monthly price verification, and the rule that nothing about the score depends on how much we get paid.
By the numbers
The work behind every page you read. Counts refreshed quarterly.
Brand + compounded, verified monthly
GLP-1 × comorbidity safety pairs
Pharmacy + telehealth law per state
Dated and re-verified
Editorial mission
The first time someone shops for a GLP-1, they meet a market designed to confuse them. Brand vs compounded. Cash-pay vs insurance. 503A vs 503B pharmacies. Telehealth states that allow synchronous video but not asynchronous chat. A list price of $1,349 next to a coupon price of $499 next to a compounded vial at $199 — same active ingredient, wildly different regulatory weight.
We built GLP1Zoom to flatten that confusion into a decision a non-clinician can make with their doctor. Every partner we list is verified hands-on by an editor who signed up for the intake. Every clinical claim is sourced to current FDA labeling and named clinical trials and dated. Every price has a “Verified Xd ago” timestamp so you know how stale it is.
We make money when you sign up with a partner through us. We've made the editorial rules public on this page and on /methodology so you can hold us to them. If you ever spot a recommendation that smells like a commission rate dressed as advice, email [email protected] — every report gets investigated.
Editorial principles
Four principles, written down so we can be held to them.
Editorial ratings are independent of commission rate. We will publish a critical review of a partner that pays us if the facts warrant it.
Every price is verified monthly with the partner. Clinical claims cite the FDA prescribing information or a peer-reviewed trial.
We earn commission when you sign up with a partner. We do not run pharma display ads, sponsored content, or paid placements.
Medical and regulatory content is rewritten for a 9th-grade reading level without dropping accuracy. Sources cited at the bottom.
Editorial standards
GLP1Zoom is an independent comparison site — not a pharmacy or medical provider, and we don't give medical advice. Here's how we keep the drug facts, prices, and claims on every page accurate and verifiable.
Drug facts — approvals, dosing, and boxed warnings — are taken from current FDA prescribing information, not summarized from memory.
Prices, news, and coverage carry a last-reviewed date, and we re-check time-sensitive claims rather than let them go stale.
Clinical claims cite the trial or journal (with DOI) or the FDA/CMS source, so you can verify them yourself.
GLP1Zoom is an independent comparison site, not a pharmacy or clinician. Nothing here is medical advice or an endorsement of a partner provider.
Read more in our Editorial Policy · review & sourcing standards.
Methodology
How we score partners →
Editorial policy
Our review process →
Editorial Standards \& Review
Reviewer credentials →
Editorial standards